Dr. Justin Persico, MD

Dr. Persico practices at Yale Medicine in New Haven, Connecticut.

Dr. Persico's NPI, 1558546663, was assigned on January 8, 2008. Dr. Persico graduated from Tufts University School Of Medicine in 2005. Dr. Persico holds Connecticut license 050598.

Dr. Persico's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Persico's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Persico is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Persico to 3 more hospitals and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Persico practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Persico's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Persico is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Persico's licenses on file in 3 states: Connecticut, California and Massachusetts.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphedema among the conditions Dr. Persico treats.

CMS data shows 941 Medicare services from Dr. Persico across 10 procedure codes in 2024, for 291 Medicare patients. Medicare paid $52,768 for them.

CMS counts 291 Medicare patients who saw Dr. Persico in 2024. The largest group is 75 to 84, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Persico's median patient age at 73, with 51% women.

In 2024, Dr. Persico wrote 1,445 Medicare Part D claims for 230 patients. 77% of them were for generic drugs. CMS names the drug for 1,118 of them, across 41 drugs with 11 or more claims each, at $2,767,795 in total drug cost. In 2023, CMS named 1,245 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Persico for performance year 2024, reported as part of a group. Dr. Persico accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Persico as offering telehealth.

Dmand AI links 5 papers to Dr. Persico, published from 2021 to 2023. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Neoadjuvant Therapy. Dr. Persico has published most often in NPJ Breast Cancer. Dr. Persico's most frequent co-authors are Kerin Bess Adelson, MD, Anees B. Chagpar, MD and Julia Foldi, MD.

CMS Open Payments shows 9 general payments to Dr. Persico from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. Merck Sharp & Dohme Corporation paid the most, $115.

Dr. Persico graduated from Tufts University School Of Medicine in 2005.

Dr. Persico is in network with 17 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.